Brief original
Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic
Metaanálisis para evaluar el riesgo de infecciones respiratorias y síndrome de distrés respiratorio del adulto con los agonistas del receptor del péptido similar al glucagón tipo 1 en los ensayos de seguridad cardiovascular: consecuencias útiles para la pandemia de COVID-19
a Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Thessaloniki, Greece
b Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Thessaloniki, Greece
c Veterans Affairs Medical Center, George Washington University, Washington, District of Columbia, Columbia, United States
Read
1305
Timeswas read the article
47
Total PDF
1258
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 1 | 0 | 1 |
| 2025 5 | 25 | 0 | 25 |
| 2025 4 | 40 | 0 | 40 |
| 2025 3 | 45 | 0 | 45 |
| 2025 2 | 27 | 0 | 27 |
| 2025 1 | 17 | 0 | 17 |
| 2024 12 | 25 | 0 | 25 |
| 2024 11 | 32 | 0 | 32 |
| 2024 10 | 56 | 0 | 56 |
| 2024 9 | 24 | 0 | 24 |
| 2024 8 | 37 | 0 | 37 |
| 2024 7 | 34 | 0 | 34 |
| 2024 6 | 19 | 0 | 19 |
| 2024 5 | 25 | 1 | 26 |
| 2024 4 | 20 | 0 | 20 |
| 2024 3 | 20 | 0 | 20 |
| 2024 2 | 21 | 0 | 21 |
| 2024 1 | 16 | 0 | 16 |
| 2023 12 | 18 | 0 | 18 |
| 2023 11 | 38 | 0 | 38 |
| 2023 10 | 17 | 0 | 17 |
| 2023 9 | 22 | 0 | 22 |
| 2023 8 | 16 | 0 | 16 |
| 2023 7 | 32 | 0 | 32 |
| 2023 6 | 30 | 0 | 30 |
| 2023 5 | 33 | 3 | 36 |
| 2023 4 | 28 | 0 | 28 |
| 2023 3 | 32 | 6 | 38 |
| 2023 2 | 20 | 0 | 20 |
| 2023 1 | 28 | 0 | 28 |
| 2022 12 | 28 | 3 | 31 |
| 2022 11 | 34 | 0 | 34 |
| 2022 10 | 34 | 5 | 39 |
| 2022 9 | 43 | 2 | 45 |
| 2022 8 | 27 | 6 | 33 |
| 2022 7 | 32 | 3 | 35 |
| 2022 6 | 29 | 1 | 30 |
| 2022 5 | 58 | 5 | 63 |
| 2022 4 | 62 | 6 | 68 |
| 2022 3 | 25 | 2 | 27 |
| 2022 2 | 22 | 4 | 26 |
| 2022 1 | 19 | 0 | 19 |
| 2021 12 | 9 | 0 | 9 |
| 2021 11 | 5 | 0 | 5 |
| 2021 8 | 1 | 0 | 1 |
| 2021 6 | 32 | 0 | 32 |
Show all
